Cerebral Organoids

Cerebral organoids are an emerging cutting-edge technology to model human brain development and neurodevelopmental disorders. Here is the latest research.

December 7, 2021

Activity-induced instabilities of brain organoids.

The European Physical Journal. E, Soft Matter
Kristian ThijssenAmin Doostmohammadi
December 6, 2021
Open Access

The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons.

Frontiers in Molecular Neuroscience
Davin LeeSung Bae Lee
December 5, 2021
Open Access

The novel BET inhibitor UM-002 reduces glioblastoma cell proliferation and invasion.

Scientific Reports
Anna M JermakowiczNagi G Ayad
December 4, 2021

Microglia modulate neurodevelopment in human neuroimmune organoids.

Cell Stem Cell
Mariko L BennettGuo-Li Ming
December 3, 2021
Preprint
Open Access

Imaging Three-Dimensional Brain Organoid Architecture from Meso- to Nanoscale across Development

BioRxiv : the Preprint Server for Biology
J. E. Rodriguez-GaticaUlrich Kubitscheck
December 3, 2021
Open Access

Human Cerebral Organoid Implantation Alleviated the Neurological Deficits of Traumatic Brain Injury in Mice.

Oxidative Medicine and Cellular Longevity
Zhongyuan BaoJing Ji
November 30, 2021
Preprint
Open Access

The HUSH complex controls brain architecture and protocadherin fidelity

BioRxiv : the Preprint Server for Biology
A. HagelkruysJosef M Penninger
November 28, 2021
Review
Open Access

Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS.

Pathogens
Hannah K HopkinsKelli L Barr
November 28, 2021
Review
Open Access

WWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives.

Cells
Daniel J Steinberg, Rami I Aqeilan
November 25, 2021
Review

Harnessing cerebral organoids for Alzheimer's disease research.

Current Opinion in Neurobiology
Adele Bubnys, Li-Huei Tsai
November 23, 2021
Preprint
Open Access

Patient brain organoids identify a link between the 16p11.2 copy number variant and the RBFOX1 gene.

BioRxiv : the Preprint Server for Biology
M. KosticRobert Ihry
November 22, 2021

Neurodegenerative brain models vs. cell replacement or restoration therapy: A review on promises and pitfalls.

Biochemical and Biophysical Research Communications
Dhiraj Kumar, Md Imtaiyaz Hassan
November 23, 2021
Review

3D hydrogel models of the neurovascular unit to investigate blood-brain barrier dysfunction.

Neuronal Signaling
Geoffrey PotjewydNigel M Hooper
November 19, 2021
Review
Open Access

Human Organoids for Predictive Toxicology Research and Drug Development.

Frontiers in Genetics
Toshikatsu Matsui, Tadahiro Shinozawa
November 15, 2021
Review

Human brain organogenesis: Toward a cellular understanding of development and disease.

Cell
Kevin W Kelley, Sergiu P Pașca
November 12, 2021
Review
Open Access

Recent Advances of COVID-19 Modeling Based on Regenerative Medicine.

Frontiers in Cell and Developmental Biology
Bagher LarijaniBabak Arjmand
November 10, 2021

Classics never get old: neurotransmitters shape human cortical interneuron migration.

The EMBO Journal
Antonela BonafinaLaurent Nguyen

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/cerebral-organoids/3d39a54c-235b-4116-96ca-e32a2fc36949